Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

L

Loews Corp.

Sep 20 • 03:16PM ET

78.40

Dollar change -0.85
Percentage change -1.07	%

Financial • Insurance - Property & Casualty • USA • NYSE

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VOO VO SPY IVV VTV RSP VOE XLF SPLV

Index	S&P 500	P/E	11.50	EPS (ttm)	6.82	Insider Own	17.27%	Shs Outstand	222.17M	Perf Week	0.08%
Market Cap	17.21B	Forward P/E	-	EPS next Y	-	Insider Trans	-1.58%	Shs Float	181.60M	Perf Month	-0.86%
Income	1.52B	PEG	0.82	EPS next Q	-	Inst Own	59.39%	Short Float	0.96%	Perf Quarter	2.40%
Sales	16.68B	P/S	1.03	EPS this Y	-	Inst Trans	-3.49%	Short Ratio	2.74	Perf Half Y	1.28%
Book/sh	74.57	P/B	1.05	EPS next Y	-	ROA	1.93%	Short Interest	1.74M	Perf Year	20.67%
Cash/sh	-	P/C	-	EPS next 5Y	14.03%	ROE	9.84%	52W Range	61.43 - 83.54	Perf YTD	12.66%
Dividend Est.	-	P/FCF	6.03	EPS past 5Y	25.93%	ROI	6.11%	52W High	-6.15%	Beta	0.82
Dividend TTM	0.25 (0.32%)	Quick Ratio	-	Sales past 5Y	2.70%	Gross Margin	-	52W Low	27.62%	ATR (14)	1.22
Dividend Ex-Date	Aug 21, 2024	Current Ratio	0.67	EPS Y/Y TTM	30.00%	Oper. Margin	14.42%	RSI (14)	44.64	Volatility	1.17% 1.46%
Employees	12280	Debt/Eq	0.58	Sales Y/Y TTM	11.77%	Profit Margin	9.14%	Recom	3.00	Target Price	82.00
Option/Short	Yes / Yes	LT Debt/Eq	0.52	EPS Q/Q	5.45%	Payout	3.97%	Rel Volume	0.60	Prev Close	79.25
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	9.75%	Earnings	Jul 29 BMO	Avg Volume	635.40K	Price	78.40
SMA20	-2.03%	SMA50	-0.70%	SMA200	4.05%	Trades		Volume	339,693	Change	-1.07%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-02-16	Reiterated	Deutsche Bank	Hold	$42 → $43
Aug-06-15	Reiterated	Deutsche Bank	Hold	$48 → $44
Mar-24-14	Downgrade	Deutsche Bank	Buy → Hold	$53 → $51
Sep-04-13	Initiated	Deutsche Bank	Buy	$52
Jun-23-09	Initiated	Susquehanna Financial	Positive

Sep-09-24 04:15PM	Loews Corporation Announces Favorable Resolution of Boardwalk Pipelines Acquisition Litigation (PR Newswire)
Aug-26-24 07:01PM	Insider Sale: Kenneth Siegel Divests Shares of Loews Corp (L) (GuruFocus.com)
Aug-06-24 11:12AM	LOEWS CORPORATION ANNOUNCES QUARTERLY DIVIDEND ON COMMON STOCK (PR Newswire)
Aug-02-24 06:17AM	3 Holding Company Stocks to Buy Other Than Berkshire Hathaway (InvestorPlace)
Jul-30-24 01:06AM	Loews Corp (L) Uncovered: Key Opportunities and Threats Ahead (GuruFocus.com)
03:31PM	Loading…
Jul-29-24 03:31PM	Wall Street is still jittery on GLP-1s (Yahoo Finance)
12:29PM	Top Stock Movers Now: Tesla, Onsemi, McDonald's, and More (Investopedia)
08:52AM	Loews Clocks Strong Q2 Performance, CEO James Tisch To Retire, Benjamin Tisch Named Successor (Benzinga)
07:54AM	Loews CEO James Tisch to step down after 25 years (Reuters)
06:08AM	Loews: Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	LOEWS CORPORATION REPORTS NET INCOME OF $369 MILLION FOR THE SECOND QUARTER OF 2024 (PR Newswire)
06:00AM	Loews Corporation Announces CEO Transition: (PR Newswire)
Jul-09-24 10:00AM	Loews Corporation to Release Second Quarter 2024 Results on July 29, 2024 (PR Newswire)
Jun-03-24 12:54PM	Loews Hotels' Tisch: Pent-up demand for lodging has waned while other areas are getting stronger (CNBC TV)
May-22-24 07:06PM	Insider Sale: SVP & Chief Investment Officer Richard Scott Sells 9,045 Shares of Loews Corp (L) (GuruFocus.com)
10:41AM	Loading…
May-14-24 10:41AM	LOEWS CORPORATION ANNOUNCES QUARTERLY DIVIDEND ON COMMON STOCK (PR Newswire)
May-07-24 05:01PM	Loews Corp (L) (Q1 2024) Earnings Call Transcript Highlights: Strong Performance with Notable ... (GuruFocus.com)
09:53AM	CNA Financial Corporation (NYSE:CNA) Q1 2024 Earnings Call Transcript (Insider Monkey)
01:03AM	Decoding Loews Corp (L): A Strategic SWOT Insight (GuruFocus.com)
May-06-24 10:53AM	L Stock Earnings: Loews Reported Results for Q1 2024 (InvestorPlace)
10:20AM	The Marcus Corporation (NYSE:MCS) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:02AM	Loews Corp (L) Reports Strong First Quarter 2024 Earnings, Net Income Rises 22% (GuruFocus.com)
07:02AM	Loews reports higher profit on strong returns on investment income (Reuters)
06:08AM	Loews: Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	LOEWS CORPORATION REPORTS NET INCOME OF $457 MILLION FOR THE FIRST QUARTER OF 2024 (PR Newswire)
May-03-24 06:00AM	Loblaw Releases 2023 ESG Report (PR Newswire)
Apr-16-24 10:00AM	Loews Corporation to Release First Quarter 2024 Results on May 6, 2024 (PR Newswire)
Mar-06-24 11:29PM	Senior Vice President Kenneth Siegel Sells 6,322 Shares of Loews Corp (L) (GuruFocus.com)
Feb-13-24 11:30AM	Loews Arlington Hotel and Convention Center Officially Opens Its Doors (PR Newswire)
Feb-06-24 11:31AM	LOEWS CORPORATION ANNOUNCES QUARTERLY DIVIDEND ON COMMON STOCK (PR Newswire)
08:41AM	Loading…
08:41AM	CNA Financial Corporation (NYSE:CNA) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:14AM	Loews Corporation (NYSE:L) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-05-24 04:19PM	Loews Hotels Pursues $435 Million Expansion in Texas and Florida (Skift)
07:01AM	Loews Corp (L) Reports Strong Earnings Growth in Q4 and Full Year 2023 (GuruFocus.com)
06:59AM	Loews fourth-quarter profit jumps on investment income gains (Reuters)
06:25AM	Loews: Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	LOEWS CORPORATION REPORTS NET INCOME OF $446 MILLION FOR THE FOURTH QUARTER OF 2023 AND $1.4 BILLION FOR THE FULL YEAR (PR Newswire)
Jan-16-24 10:00AM	Loews Corporation to Release Fourth Quarter 2023 Results on February 5, 2024 (PR Newswire)
Dec-13-23 10:28AM	15 Best Property and Casualty Insurance Companies Heading into 2024 (Insider Monkey)
Dec-02-23 03:05AM	Insider Sell Alert: Kenneth Siegel Offloads Shares of Loews Corp (GuruFocus.com)
Nov-13-23 10:00AM	Inside Amazon's robot empire (Yahoo Finance Video)
Nov-07-23 11:46AM	LOEWS CORPORATION ANNOUNCES QUARTERLY DIVIDEND ON COMMON STOCK (PR Newswire)
Nov-06-23 01:13AM	Buffett sells BYD shares; a 51% WeWork bid: Insider trades & hedge funds weekly (Investing.com)
Nov-02-23 01:04AM	Director Jonathan Locker Buys 15,870 Shares of Loews Corp (GuruFocus.com)
Oct-30-23 08:12AM	Loews Corp (L) Reports Q3 2023 Net Income of $253 Million (GuruFocus.com)
07:19AM	Loews posts Q3 profit on higher investment income, insurance premium (Reuters)
06:11AM	Loews: Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	LOEWS CORPORATION REPORTS NET INCOME OF $253 MILLION FOR THE THIRD QUARTER OF 2023 (PR Newswire)
04:04AM	McDonald's, Ford, Southwest Airlines rise premarket; Cisco fell (Investing.com)
Oct-10-23 10:00AM	Loews Corporation to Release Third Quarter 2023 Results on October 30, 2023 (PR Newswire)
Sep-29-23 02:03PM	These 3 Insurance Stocks Trade Below Book and Pay Dividends (GuruFocus.com)
Sep-19-23 10:08AM	Loews Corporation Elects Jonathan Locker to Its Board of Directors (PR Newswire)
Sep-13-23 08:00AM	Loews Stock Tops Buy Point, A Stone's Throw From All-Time High (Investor's Business Daily)
Aug-01-23 12:04PM	LOEWS CORPORATION ANNOUNCES QUARTERLY DIVIDEND ON COMMON STOCK (PR Newswire)
06:27AM	Is Now The Time To Put Loews (NYSE:L) On Your Watchlist? (Simply Wall St.)
Jul-31-23 07:08AM	Loews profit more than doubles as market rebound boosts investment returns (Reuters)
06:07AM	Loews: Q2 Earnings Snapshot (AP Finance)
06:00AM	LOEWS CORPORATION REPORTS NET INCOME OF $360 MILLION FOR THE SECOND QUARTER OF 2023 (PR Newswire)
Jul-11-23 10:00AM	Loews Corporation to Release Second Quarter 2023 Results on July 31, 2023 (PR Newswire)
Jul-09-23 08:20AM	With 59% institutional ownership, Loews Corporation (NYSE:L) is a favorite amongst the big guns (Simply Wall St.)
Jul-07-23 10:10AM	3 Stocks to Snag for Less Than Book Value (InvestorPlace)
Jun-21-23 08:00PM	L: Lowering target price to $61.00 (Argus Research)
Jun-11-23 03:35AM	5 hot insider trades & hedge fund hits: Cathie Wood snaps up more Coinbase (Investing.com)
Jun-05-23 06:44AM	Daily Vickers Top Buyers & Sellers for 06/05/2023 (Argus Research)
Jun-04-23 08:08AM	Loews Senior VP of Corporate Development & Strategy Acquires 1,625% More Stock \ (Simply Wall St.)
Jun-02-23 12:11PM	10 Best Property & Casualty Insurance Stocks to Buy (Insider Monkey)
May-09-23 08:36AM	LOEWS CORPORATION ANNOUNCES QUARTERLY DIVIDEND ON COMMON STOCK (PR Newswire)
May-08-23 08:38AM	Are Loews Corporation's (NYSE:L) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? (Simply Wall St.)
May-01-23 04:26PM	S&P 500: Nvidia Stock Is A Top Performer, While Regional Banks Skid (Investor's Business Daily)
06:11AM	Loews: Q1 Earnings Snapshot (AP Finance)
06:00AM	LOEWS CORPORATION REPORTS NET INCOME OF $375 MILLION FOR THE FIRST QUARTER OF 2023 (PR Newswire)
Apr-26-23 08:00PM	L: Rating increased to a BUY (Argus Research)
Apr-18-23 07:00AM	Loblaw Companies Limited Announces Senior Management Changes, Effective By Q1 2024 (PR Newswire)
Apr-11-23 10:00AM	Loews Corporation to Release First Quarter 2023 Results on May 1, 2023 (PR Newswire)
Mar-24-23 07:30AM	Loblaw Companies Limited Enters into Automatic Share Purchase Plan (PR Newswire)
Mar-20-23 07:33AM	Loews' (NYSE:L) three-year total shareholder returns outpace the underlying earnings growth (Simply Wall St.)
Feb-08-23 07:20PM	Loews Stock Cools In Sync With Market After Strong Recent Gains (Investor's Business Daily)
Feb-06-23 06:00AM	LOEWS CORPORATION REPORTS NET INCOME OF $364 MILLION FOR THE FOURTH QUARTER OF 2022 AND $1.0 BILLION FOR THE FULL YEAR (PR Newswire)
Jan-29-23 09:19AM	A great week that adds to Loews Corporation's (NYSE:L) one-year returns, institutional investors who own 61% must be happy (Simply Wall St.)
Jan-24-23 10:00AM	Loews Corporation to Release Fourth Quarter 2022 Results on February 6, 2023 (PR Newswire)
12:00AM	US court reins in the questioning of the intent of corporate lawyers (Financial Times)
Dec-20-22 11:20AM	Loews Wins Appeal Over $690 Million Damages Award to Hedge Fund (Bloomberg)
Nov-28-22 01:10PM	Loews Corporation's (NYSE:L) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock? (Simply Wall St.)
Nov-08-22 06:04AM	Loews Third Quarter 2022 Earnings: EPS: US$0.54 (vs US$0.86 in 3Q 2021) (Simply Wall St.)
Nov-03-22 11:32AM	LOEWS CORAL GABLES OFFICIALLY OPENS ITS DOORS (PR Newswire)
Oct-31-22 06:20AM	Loews Hotels & Co Appoints Alex Tisch CEO (PR Newswire)
06:10AM	Loews Corporation announces management changes at Loews Hotels & Co: Jonathan Tisch to assume Executive Chairman Position; Alex Tisch to become President and CEO (PR Newswire)
06:00AM	LOEWS CORPORATION REPORTS NET INCOME OF $130 MILLION FOR THE THIRD QUARTER OF 2022 (PR Newswire)
Oct-18-22 10:05AM	Loews Corporation to Release Third Quarter 2022 Results on October 31, 2022 (PR Newswire)
Oct-10-22 01:43PM	The past one-year earnings decline for Loews (NYSE:L) likely explains shareholders long-term losses (Simply Wall St.)
Aug-22-22 08:22AM	With 62% ownership of the shares, Loews Corporation (NYSE:L) is heavily dominated by institutional owners (Simply Wall St.)
Aug-19-22 09:13AM	Altium Packaging LLC -- Moody's says Altium's ratings not impacted by senior secured term loan add-on (Moody's)
Aug-07-22 10:30AM	Bearish Bets: 3 Stocks You Really Should Consider Shorting This Week (TheStreet.com)
Aug-01-22 06:00AM	LOEWS CORPORATION REPORTS NET INCOME OF $180 MILLION FOR THE SECOND QUARTER OF 2022 (PR Newswire)
Jul-20-22 11:30AM	Loews Hotels & Co Tops Off the $550 Million, 888-room Loews Arlington Hotel and Arlington Convention Center and Names Soy Cowboy as Hotel's Signature Restaurant Anchor (PR Newswire)
Jul-19-22 10:14AM	Loews Corporation to Release Second Quarter 2022 Results on August 1, 2022 (PR Newswire)
Jun-19-22 08:27AM	Should Weakness in Loews Corporation's (NYSE:L) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? (Simply Wall St.)
May-10-22 12:00PM	Loews Corporation Promotes Benjamin Tisch to Senior Vice President, Corporate Development and Strategy (PR Newswire)
May-03-22 12:38PM	Loews' (NYSE:L) earnings growth rate lags the 6.2% CAGR delivered to shareholders (Simply Wall St.)
May-02-22 06:12AM	Loews earnings rise, but revenue falls as investment income swings to negative due to rise in interest rates (MarketWatch)

Loews Corp. is a holding company, which engages in the business of commercial property and casualty insurance, transportation and storage of natural gas and natural gas liquids, and operation of a chain of hotels. It operates through the following segments: CNA Financial, Boardwalk Pipelines, Loews Hotels and Co, and Corporate. The CNA Financial segment is involved in the sale of property and casualty insurance products and services, including surety, primarily through a network of independent agents, brokers, and managing general underwriters. The Boardwalk Pipelines segment focuses on midstream portion of the natural gas and NGLs industry, providing transportation, and storage for those commodities. The Loews Hotels and Co segment refers to a chain of hotels, which are in the United States and one of which is in Canada. The Corporate segment consists of investment income from the parent company's cash and investments, parent company interest expense, and other unallocated parent company expenses. The company was founded by Laurence A. Tisch and Preston Robert Tisch on November 12, 1969 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Sep 06 '24	Sale	79.67	37,500	2,987,594	6,744,134	Sep 10 04:16 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Sep 06 '24	Sale	79.67	25,000	1,991,729	411,395	Sep 10 04:16 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Sep 04 '24	Sale	82.01	75,000	6,150,691	6,844,134	Sep 05 05:00 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Sep 03 '24	Sale	81.82	75,000	6,136,500	6,919,134	Sep 05 05:00 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Sep 05 '24	Sale	80.84	62,500	5,052,500	6,781,634	Sep 05 05:00 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Sep 04 '24	Sale	82.01	25,000	2,050,230	436,395	Sep 05 05:00 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Sep 03 '24	Sale	81.82	25,000	2,045,500	461,395	Sep 05 05:00 PM
BERMAN ANN E	Director	Sep 03 '24	Option Exercise	41.98	2,250	94,455	7,248	Sep 04 04:22 PM
BERMAN ANN E	Director	Sep 03 '24	Sale	81.38	1,087	88,460	4,998	Sep 04 04:22 PM
DIKER CHARLES M	Director	Sep 03 '24	Option Exercise	41.98	2,250	94,455	22,156	Sep 04 04:20 PM
DIKER CHARLES M	Director	Sep 03 '24	Sale	81.37	1,088	88,531	19,906	Sep 04 04:20 PM
FRIBOURG PAUL J	Director	Sep 03 '24	Option Exercise	41.98	2,250	94,455	2,250	Sep 04 04:19 PM
FRIBOURG PAUL J	Director	Sep 03 '24	Sale	81.41	1,088	88,574	0	Sep 04 04:19 PM
HARRIS WALTER L	Director	Sep 03 '24	Option Exercise	41.98	2,250	94,455	25,156	Sep 04 04:18 PM
HARRIS WALTER L	Director	Sep 03 '24	Sale	81.41	1,088	88,574	22,906	Sep 04 04:18 PM
WELTERS ANTHONY	Director	Sep 03 '24	Option Exercise	41.98	2,250	94,455	12,095	Sep 04 04:15 PM
WELTERS ANTHONY	Director	Sep 03 '24	Sale	81.41	1,088	88,574	9,845	Sep 04 04:15 PM
TISCH JONATHAN M	Officer	Sep 03 '24	Proposed Sale	81.94	325,000	26,630,500		Sep 03 06:19 PM
HARRIS WALTER L	Director	Sep 03 '24	Proposed Sale	81.41	1,088	88,578		Sep 03 01:50 PM
FRIBOURG PAUL J	Director	Sep 03 '24	Proposed Sale	81.41	1,088	88,578		Sep 03 01:18 PM
DIKER CHARLES M	Director	Sep 03 '24	Proposed Sale	81.37	1,088	88,529		Sep 03 12:59 PM
WELTERS ANTHONY	Director	Sep 03 '24	Proposed Sale	81.41	1,088	88,574		Sep 03 12:40 PM
BERMAN ANN E	Director	Sep 03 '24	Proposed Sale	81.38	1,087	88,460		Sep 03 12:37 PM
SIEGEL KENNETH I	Senior Vice President	Aug 23 '24	Sale	80.21	6,993	560,909	0	Aug 26 04:15 PM
KENNETH SIEGEL	Officer	Aug 23 '24	Proposed Sale	80.21	6,993	560,901		Aug 23 04:06 PM
Alpert Marc A	Sr. VP, Gen. Coun. & Secy.	Aug 12 '24	Sale	77.21	7,000	540,470	10,000	Aug 13 04:16 PM
Alpert Marc A	Officer	Aug 12 '24	Proposed Sale	77.21	7,000	540,454		Aug 12 04:26 PM
SCHWARTZ MARK S	V.P., C.A.O. and Treasurer	Jul 30 '24	Sale	80.88	2,628	212,553	14,933	Jul 31 04:20 PM
Locker Jonathan C	Director	Jul 30 '24	Buy	80.63	6,200	499,896	23,068	Jul 31 04:18 PM
Alpert Marc A	Sr. VP, Gen. Coun. & Secy.	Jul 30 '24	Sale	80.79	2,687	217,083	17,000	Jul 31 04:17 PM
Alpert Marc A	Officer	Jul 30 '24	Proposed Sale	80.79	2,687	217,083		Jul 30 02:49 PM
HARRIS WALTER L	Director	Jun 03 '24	Option Exercise	43.83	2,250	98,618	25,156	Jun 04 04:23 PM
HARRIS WALTER L	Director	Jun 03 '24	Sale	75.80	963	72,995	22,906	Jun 04 04:23 PM
FRIBOURG PAUL J	Director	Jun 03 '24	Option Exercise	43.83	2,250	98,618	2,250	Jun 04 04:22 PM
FRIBOURG PAUL J	Director	Jun 03 '24	Sale	75.80	963	72,995	0	Jun 04 04:22 PM
DIKER CHARLES M	Director	Jun 03 '24	Option Exercise	43.83	2,250	98,618	22,156	Jun 04 04:20 PM
DIKER CHARLES M	Director	Jun 03 '24	Sale	75.79	963	72,987	19,906	Jun 04 04:20 PM
BERMAN ANN E	Director	Jun 03 '24	Option Exercise	43.83	2,250	98,618	7,248	Jun 04 04:18 PM
BERMAN ANN E	Director	Jun 03 '24	Sale	75.80	963	72,995	4,998	Jun 04 04:18 PM
WELTERS ANTHONY	Director	Jun 03 '24	Option Exercise	43.83	2,250	98,618	12,095	Jun 04 04:17 PM
WELTERS ANTHONY	Director	Jun 03 '24	Sale	75.80	963	72,995	9,845	Jun 04 04:17 PM
SCOTT RICHARD WALDO	SVP & Chief Investment Officer	May 21 '24	Sale	76.34	9,045	690,495	42,920	May 22 04:17 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	May 17 '24	Sale	77.60	50,000	3,880,000	407,799	May 20 04:57 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	May 14 '24	Sale	77.24	50,000	3,862,000	507,799	May 16 05:03 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	May 16 '24	Sale	77.14	50,000	3,857,000	457,799	May 16 05:03 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	May 09 '24	Sale	77.41	50,000	3,870,500	557,799	May 10 04:18 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	May 08 '24	Sale	77.39	50,000	3,869,500	607,799	May 10 04:18 PM
Locker Jonathan C	Director	May 09 '24	Option Exercise	0.00	998	0	16,868	May 09 08:42 AM
WELTERS ANTHONY	Director	May 09 '24	Option Exercise	0.00	1,706	0	9,845	May 09 08:40 AM
HARRIS WALTER L	Director	May 09 '24	Option Exercise	0.00	1,706	0	22,906	May 09 08:38 AM
DIKER CHARLES M	Director	May 09 '24	Option Exercise	0.00	1,706	0	19,906	May 09 08:37 AM
DAVIDSON CHARLES D	Director	May 09 '24	Option Exercise	0.00	1,706	0	26,906	May 09 08:35 AM
BERMAN ANN E	Director	May 09 '24	Option Exercise	0.00	1,706	0	4,998	May 09 08:34 AM
TISCH ANDREW H	Director	May 09 '24	Option Exercise	0.00	1,706	0	1,726,479	May 09 08:32 AM
SIEGEL KENNETH I	Senior Vice President	Mar 06 '24	Sale	75.50	6,322	477,311	6,993	Mar 06 04:18 PM
FRIBOURG PAUL J	Director	Mar 01 '24	Option Exercise	43.37	2,250	97,582	2,250	Mar 04 07:09 PM
FRIBOURG PAUL J	Director	Mar 01 '24	Sale	75.02	951	71,344	0	Mar 04 07:09 PM
DIKER CHARLES M	Director	Mar 01 '24	Option Exercise	43.37	2,250	97,582	20,450	Mar 04 07:07 PM
DIKER CHARLES M	Director	Mar 01 '24	Sale	75.02	951	71,344	18,200	Mar 04 07:07 PM
WELTERS ANTHONY	Director	Mar 01 '24	Option Exercise	43.37	2,250	97,582	10,389	Mar 04 07:04 PM
WELTERS ANTHONY	Director	Mar 01 '24	Sale	75.01	951	71,335	8,139	Mar 04 07:04 PM
HARRIS WALTER L	Director	Mar 01 '24	Option Exercise	43.37	2,250	97,582	23,450	Mar 04 07:02 PM
HARRIS WALTER L	Director	Mar 01 '24	Sale	75.01	951	71,335	21,200	Mar 04 07:02 PM
BOWER JOSEPH L	Director	Mar 01 '24	Option Exercise	43.37	2,250	97,582	17,300	Mar 04 04:33 PM
BOWER JOSEPH L	Director	Mar 01 '24	Sale	75.01	476	35,705	15,525	Mar 04 04:33 PM
BERMAN ANN E	Director	Mar 01 '24	Option Exercise	43.37	2,250	97,582	5,542	Mar 04 04:20 PM
BERMAN ANN E	Director	Mar 01 '24	Sale	75.02	951	71,344	3,292	Mar 04 04:20 PM
TISCH ANDREW H	Director	Feb 14 '24	Sale	73.30	125,000	9,162,500	820,886	Feb 15 05:05 PM
TISCH ANDREW H	Director	Feb 13 '24	Sale	73.04	125,000	9,130,000	945,886	Feb 15 05:05 PM
SCOTT RICHARD WALDO	SVP & Chief Investment Officer	Feb 15 '24	Sale	74.12	7,325	542,929	51,965	Feb 15 05:03 PM
Alpert Marc A	Sr. VP, Gen. Coun. & Secy.	Feb 08 '24	Option Exercise	0.00	7,567	0	23,872	Feb 09 04:26 PM
Alpert Marc A	Sr. VP, Gen. Coun. & Secy.	Feb 07 '24	Option Exercise	0.00	6,578	0	19,943	Feb 09 04:26 PM
SCHWARTZ MARK S	V.P., C.A.O. and Treasurer	Feb 08 '24	Option Exercise	0.00	4,743	0	19,271	Feb 09 04:25 PM
SCHWARTZ MARK S	V.P., C.A.O. and Treasurer	Feb 07 '24	Option Exercise	0.00	4,111	0	16,011	Feb 09 04:25 PM
SCOTT RICHARD WALDO	SVP & Chief Investment Officer	Feb 08 '24	Option Exercise	0.00	7,567	0	62,018	Feb 09 04:23 PM
SCOTT RICHARD WALDO	SVP & Chief Investment Officer	Feb 07 '24	Option Exercise	0.00	6,578	0	56,823	Feb 09 04:23 PM
SIEGEL KENNETH I	Senior Vice President	Feb 08 '24	Option Exercise	0.00	7,567	0	17,500	Feb 09 04:22 PM
SIEGEL KENNETH I	Senior Vice President	Feb 07 '24	Option Exercise	0.00	6,578	0	13,571	Feb 09 04:22 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Feb 07 '24	Option Exercise	0.00	8,223	0	115,093	Feb 09 04:21 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Feb 08 '24	Option Exercise	0.00	9,592	0	116,462	Feb 09 04:21 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Feb 08 '24	Sale	71.91	4,287	308,278	106,870	Feb 09 04:21 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Feb 07 '24	Sale	72.69	3,675	267,136	106,870	Feb 09 04:21 PM
Wang Jane J.	Sr. Vice President & CFO	Feb 08 '24	Option Exercise	0.00	3,197	0	7,726	Feb 09 04:18 PM
Wang Jane J.	Sr. Vice President & CFO	Feb 07 '24	Option Exercise	0.00	4,111	0	6,803	Feb 09 04:18 PM
Tisch Alexander H	VP; Pres. & CEO, Loews Hotels	Feb 08 '24	Option Exercise	0.00	3,730	0	37,875	Feb 09 04:17 PM
Tisch Alexander H	VP; Pres. & CEO, Loews Hotels	Feb 07 '24	Option Exercise	0.00	3,700	0	34,145	Feb 09 04:17 PM
Tisch Benjamin J	Sr. VP, Corp Dev and Strategy	Feb 08 '24	Option Exercise	0.00	3,730	0	363,042	Feb 09 04:15 PM
Tisch Benjamin J	Sr. VP, Corp Dev and Strategy	Feb 07 '24	Option Exercise	0.00	3,700	0	359,312	Feb 09 04:15 PM
TISCH ANDREW H	Director	Jan 02 '24	Option Exercise	44.98	30,000	1,349,250	1,100,866	Jan 04 04:17 PM
TISCH ANDREW H	Director	Jan 03 '24	Option Exercise	42.91	30,000	1,287,150	1,100,866	Jan 04 04:17 PM
TISCH ANDREW H	Director	Jan 03 '24	Sale	70.58	11,741	828,680	1,070,866	Jan 04 04:17 PM
TISCH ANDREW H	Director	Jan 02 '24	Sale	70.15	10,629	745,624	1,070,866	Jan 04 04:17 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Jan 02 '24	Option Exercise	43.94	60,000	2,636,400	166,870	Jan 04 04:16 PM
TISCH JONATHAN M	Co-Ch. of Bd/Off. of the Pres.	Jan 02 '24	Sale	70.15	22,150	1,553,823	106,870	Jan 04 04:16 PM
WELTERS ANTHONY	Director	Dec 01 '23	Option Exercise	47.84	2,250	107,640	10,389	Dec 04 04:23 PM
WELTERS ANTHONY	Director	Dec 01 '23	Sale	70.16	715	50,164	8,139	Dec 04 04:23 PM
HARRIS WALTER L	Director	Dec 01 '23	Option Exercise	47.84	2,250	107,640	23,450	Dec 04 04:22 PM
HARRIS WALTER L	Director	Dec 01 '23	Sale	70.17	715	50,172	21,200	Dec 04 04:22 PM
FRIBOURG PAUL J	Director	Dec 01 '23	Option Exercise	47.84	2,250	107,640	2,250	Dec 04 04:20 PM
FRIBOURG PAUL J	Director	Dec 01 '23	Sale	70.21	715	50,200	0	Dec 04 04:20 PM

Open in Screener

IMRX

Immuneering Corp

Sep 20 • 03:16PM ET

3.19

Dollar change +0.77
Percentage change 31.82	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VXF CNCR IWC CHNA

Index	-	P/E	-	EPS (ttm)	-1.91	Insider Own	29.16%	Shs Outstand	29.27M	Perf Week	57.92%
Market Cap	94.58M	Forward P/E	-	EPS next Y	-1.52	Insider Trans	-3.95%	Shs Float	21.00M	Perf Month	184.82%
Income	-56.07M	PEG	-	EPS next Q	-0.55	Inst Own	32.38%	Short Float	7.24%	Perf Quarter	123.08%
Sales	0.00M	P/S	-	EPS this Y	-2.06%	Inst Trans	-2.73%	Short Ratio	0.27	Perf Half Y	16.85%
Book/sh	2.24	P/B	1.43	EPS next Y	20.72%	ROA	-55.52%	Short Interest	1.52M	Perf Year	-59.57%
Cash/sh	2.01	P/C	1.58	EPS next 5Y	-	ROE	-61.81%	52W Range	1.00 - 9.00	Perf YTD	-56.60%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-57.97%	ROI	-79.75%	52W High	-64.56%	Beta	-0.57
Dividend TTM	-	Quick Ratio	9.39	Sales past 5Y	-43.59%	Gross Margin	-168734.95%	52W Low	219.00%	ATR (14)	0.41
Dividend Ex-Date	-	Current Ratio	9.39	EPS Y/Y TTM	1.06%	Oper. Margin	0.00%	RSI (14)	77.24	Volatility	42.32% 16.43%
Employees	68	Debt/Eq	0.06	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.75	Target Price	11.21
Option/Short	No / No	LT Debt/Eq	0.06	EPS Q/Q	-11.59%	Payout	-	Rel Volume	4.65	Prev Close	2.42
Sales Surprise	-	EPS Surprise	9.62%	Sales Q/Q	-	Earnings	Aug 06 AMC	Avg Volume	5.64M	Price	3.19
SMA20	112.00%	SMA50	144.20%	SMA200	-3.59%	Trades		Volume	23,376,345	Change	31.82%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-15-24	Reiterated	Needham	Buy	$20 → $15
Mar-15-24	Downgrade	TD Cowen	Outperform → Market Perform
Mar-15-24	Downgrade	Jefferies	Buy → Hold	$16 → $3
Dec-01-23	Initiated	Needham	Buy	$20
Jun-26-23	Resumed	Oppenheimer	Outperform	$25
Apr-19-23	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$5 → $14
Apr-19-23	Upgrade	Mizuho	Neutral → Buy	$10 → $20
Mar-30-23	Initiated	Mizuho	Neutral	$10
Feb-03-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$12 → $5
Jul-08-22	Initiated	Chardan Capital Markets	Buy	$18
Apr-01-22	Initiated	Oppenheimer	Outperform	$25
Jan-07-22	Initiated	Piper Sandler	Overweight	$41

Show Previous Ratings

Sep-13-24 08:14AM	Why Is Nanocap Immuneering Stock Trading Higher On Friday? (Benzinga) +41.26%
Sep-12-24 04:05PM	Immuneering Announces Positive Initial Phase 2a Data Including Complete and Partial Responses with IMM-1-104 in Combination with Chemotherapy in First-Line Pancreatic Cancer Patients (GlobeNewswire) +10.85%
Aug-29-24 08:00AM	Immuneering to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
Aug-06-24 04:05PM	Immuneering Reports Second Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire) -8.06%
Jul-31-24 04:05PM	Immuneering Granted FDA Fast Track Designation for IMM-1-104 in First-line Pancreatic Cancer (GlobeNewswire) +19.47%
04:05PM	Loading…
May-29-24 04:05PM	Immuneering to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-17-24 12:50PM	Early Detection Breakthrough: Biotech Companies Lead the Way in Pancreatic Cancer Treatment (PR Newswire)
May-07-24 10:55PM	IMRX Stock Earnings: Immuneering Misses EPS for Q1 2024 (InvestorPlace) -5.45%
04:05PM	Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
May-06-24 04:30PM	Immuneering Recognizes Melanoma Awareness Month (GlobeNewswire)
Apr-09-24 12:00PM	IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models (GlobeNewswire)
Apr-03-24 04:05PM	Immuneering to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-27-24 08:00AM	Immuneering Announces First Patient Dosed in its Phase 1/2a Trial of IMM-6-415 to Treat Advanced Solid Tumors with RAF or RAS Mutations (GlobeNewswire)
Mar-18-24 11:02AM	Immuneering (IMRX) Plummets 71% in One Week: Here's Why (Zacks) +34.03%
Mar-14-24 07:00AM	Immuneering Announces Positive Topline Results from Phase 1 Portion of its Phase 1/2a Clinical Trial of IMM-1-104 in RAS-Mutant Solid Tumors (GlobeNewswire) -50.68%
08:00AM	Loading…
Mar-12-24 08:00AM	Immuneering Appoints Thomas J. Schall, Ph.D. to its Board of Directors (GlobeNewswire)
Mar-11-24 08:00AM	Immuneering Doses First Patient in Phase 2a Clinical Trial of IMM-1-104 in RAS-mutant Solid Tumors (GlobeNewswire) -9.53%
Mar-06-24 08:00AM	Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning (Newsfile)
Mar-05-24 05:00PM	Immuneering to Present Preclinical Data on Universal-RAS Program IMM-1-104 at American Association for Cancer Research Annual Meeting 2024 (GlobeNewswire)
Mar-04-24 08:00AM	Immuneering to Participate in the Cowen 44th Annual Health Care Conference (GlobeNewswire)
Mar-03-24 07:01PM	Immuneering Corp (IMRX) Reports Q4 and Full Year 2023 Financial Results (GuruFocus.com)
Mar-01-24 08:00AM	Immuneering Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Feb-20-24 08:00AM	Immuneering Receives FDA Fast Track Designation for IMM-1-104 in Pancreatic Cancer (GlobeNewswire)
Feb-14-24 03:45PM	3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave (InvestorPlace) +8.00%
Feb-01-24 08:00AM	Immuneering Announces Participation in February Investor Conferences (GlobeNewswire)
Dec-12-23 08:00AM	Immuneering Announces FDA Clearance of IND Application for Phase 1/2a Trial of IMM-6-415 to Treat Advanced Solid Tumors with RAF or RAS Mutations (GlobeNewswire) -7.11%
Nov-20-23 04:05PM	Immuneering to Present at the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire) +25.45%
Nov-09-23 04:05PM	Immuneering Reports Third Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire) -11.86%
Oct-12-23 04:05PM	Immuneering Presents Preclinical Data Demonstrating Encouraging Anti-Tumor Activity for IMM-1-104 and IMM-6-415 at AACR-NCI-EORTC Conference (GlobeNewswire) -6.65%
Oct-04-23 04:05PM	Immuneering to Present Preclinical Data on IMM-1-104 and IMM-6-415 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire)
08:00AM	Loading…
Sep-06-23 08:00AM	Immuneering to Present at the Morgan Stanley Healthcare Conference (GlobeNewswire)
Aug-03-23 04:05PM	Immuneering Reports Second Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Aug-02-23 06:09AM	Immuneering Corporation (NASDAQ:IMRX) insiders have significant skin in the game with 28% ownership (Simply Wall St.)
Jul-05-23 09:55AM	Wall Street Analysts Think Immuneering Corporation (IMRX) Could Surge 103.8%: Read This Before Placing a Bet (Zacks)
Jun-05-23 08:00AM	Immuneering Completes Dose Escalation in the IMM-1-104 Phase 1 Clinical Trial for RAS-Mutant, Advanced Solid Tumors (GlobeNewswire)
May-30-23 08:00AM	Immuneering to Present at the Jefferies Healthcare Conference (GlobeNewswire) +6.86%
May-04-23 07:25PM	Immuneering Corporation (IMRX) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -8.75%
04:05PM	Immuneering Reports First Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Apr-18-23 09:24AM	Immuneering Announces $30 Million Underwritten Offering (GlobeNewswire) +9.60%
09:00AM	Immuneering Announces Positive Initial Phase 1 Pharmacokinetic, Pharmacodynamic and Safety Data for IMM-1-104 Universal-RAS Program; Accelerates Study Timeline (GlobeNewswire)
04:20AM	Morphic Holding, Inc. (MORF) Moves 22.5% Higher: Will This Strength Last? (Zacks)
Apr-12-23 04:05PM	Immuneering to Present at the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-11-23 03:56AM	Immuneering Corporation (IMRX) Surges 18.5%: Is This an Indication of Further Gains? (Zacks) +5.78%
Apr-05-23 08:00AM	Immuneering to Present Initial Phase 1 Pharmacokinetic, Pharmacodynamic Modeling and Safety Data for Universal-RAS Program IMM-1-104 at American Association for Cancer Research Annual Meeting 2023 (GlobeNewswire)
Mar-28-23 08:00AM	Immuneering Appoints Harold E. Brakewood as Chief Business Officer (GlobeNewswire) -7.40%
Mar-27-23 09:55AM	Wall Street Analysts Believe Immuneering Corporation (IMRX) Could Rally 102.51%: Here's is How to Trade (Zacks)
Mar-24-23 01:25PM	Why Shares of Immuneering Jumped This Week (Motley Fool)
Mar-23-23 06:18AM	Immuneering Corporation (IMRX) Soars 16.9%: Is Further Upside Left in the Stock? (Zacks)
Mar-14-23 04:30PM	Immuneering to Present Data on Universal-RAS Program IMM-1-104 at American Association for Cancer Research Annual Meeting 2023 (GlobeNewswire) +5.62% -8.05%
Mar-09-23 09:55AM	Does Immuneering Corporation (IMRX) Have the Potential to Rally 210.19% as Wall Street Analysts Expect? (Zacks) +5.47%
Mar-08-23 07:14AM	Immuneering Corporation (NASDAQ:IMRX) Q4 2022 Earnings Call Transcript (Insider Monkey) +22.87%
Mar-06-23 05:45PM	Immuneering Corporation (IMRX) Reports Q4 Loss, Misses Revenue Estimates (Zacks) +6.17%
04:05PM	Immuneering Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates (GlobeNewswire)
Mar-05-23 06:30PM	Immuneering Presents Preclinical Data with Lead Program IMM-1-104 Supporting Universal-RAS Activity (GlobeNewswire)
Feb-28-23 08:00AM	Immuneering Announces Participation in March Investor Conferences (GlobeNewswire)
Feb-27-23 08:00AM	Immuneering to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates (GlobeNewswire)
Feb-05-23 07:18AM	Immuneering Corporation (NASDAQ:IMRX) insiders, who hold 31% of the firm would be disappointed by the recent pullback (Simply Wall St.)
Jan-31-23 06:50AM	Immuneering To Present at Guggenheim 2023 Oncology Conference (GlobeNewswire)
Nov-28-22 06:50AM	Immuneering Announces First Patient Dosed in its Phase 1/2a Clinical Trial of IMM-1-104 in Advanced Solid Tumors with RAS Mutations (GlobeNewswire)
Nov-16-22 06:35AM	Immuneering Third Quarter 2022 Earnings: Revenues Disappoint (Simply Wall St.)
Nov-10-22 10:15AM	Immuneering Corporation (IMRX) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
09:00AM	Immuneering Reports Third Quarter 2022 Financial Results and Recent Business Highlights (GlobeNewswire)
09:00AM	Immuneering Presents Promising Preclinical Data on its Second Program IMM-6-415 at the 37th Annual Meeting of SITC (GlobeNewswire)
Nov-03-22 06:50AM	Immuneering Announces Participation in November Investor Conferences (GlobeNewswire) -12.80%
Oct-20-22 06:50AM	Immuneering Appoints Leah R. Neufeld as Chief People Officer (GlobeNewswire)
Oct-05-22 08:05AM	Immuneering To Present Poster on IMM-6-415 at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) (GlobeNewswire) -5.80%
Sep-30-22 12:00PM	What Makes Immuneering Corporation (IMRX) a New Buy Stock (Zacks) +9.15%
06:50AM	Immuneering Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of IMM-1-104 to Treat Advanced Solid Tumors with RAS Mutations (GlobeNewswire)
Sep-12-22 09:55AM	Wall Street Analysts See a 148% Upside in Immuneering Corporation (IMRX): Can the Stock Really Move This High? (Zacks) +10.82%
Sep-05-22 10:21AM	Immuneering (IMRX) Files IND for Cancer Candidate IMM-1-104 (Zacks)
Sep-02-22 08:09AM	Immuneering Announces Submission of IND Application to the FDA for Phase 1/2a Trial of IMM-1-104 to Treat Advanced Solid Tumors with RAS Mutations (GlobeNewswire) +7.05%
Aug-25-22 09:55AM	Wall Street Analysts Believe Immuneering Corporation (IMRX) Could Rally 224%: Here's is How to Trade (Zacks) -7.35%
06:50AM	Immuneering Announces Participation in September Investor Conferences (GlobeNewswire)
Aug-10-22 05:55PM	Immuneering Corporation (IMRX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Immuneering Reports Second Quarter 2022 Financial Results and Recent Business Highlights (GlobeNewswire)
Aug-08-22 12:24PM	Immuneering (NASDAQ:IMRX) shareholders have endured a 77% loss from investing in the stock a year ago (Simply Wall St.) +11.25%
Jul-22-22 10:01AM	Lumos (LUMO) Soars 9.4%: Is Further Upside Left in the Stock? (Zacks)
Jul-11-22 07:57AM	What Type Of Shareholders Own The Most Number of Immuneering Corporation (NASDAQ:IMRX) Shares? (Simply Wall St.)
Jul-08-22 11:40AM	Why This Small-Cap Stock Is Gaining More Than 10% Today? (Benzinga) +28.85%
Jul-06-22 06:50AM	Immuneering Announces Participation in William Blair Biotech Focus Conference 2022 (GlobeNewswire) +5.80%
May-26-22 05:26PM	Immuneering Reports Data in Two Preclinical Abstracts at the ASCO 2022 Annual Meeting Highlighting Pan-KRAS/NRAS Activity of IMM-1-104 (GlobeNewswire) +11.31% +6.70%
May-20-22 06:50AM	Immuneering Announces Participation in Upcoming Investor Conferences (GlobeNewswire)
May-10-22 06:30AM	Immuneering Reports First Quarter 2022 Financial Results and Recent Business Highlights (GlobeNewswire) +13.99%
May-09-22 08:54AM	Immuneering Corporation (NASDAQ:IMRX) insiders placed bullish bets worth US$10.0m in the last 12 months (Simply Wall St.) -12.63%
May-05-22 06:50AM	Immuneering Announces Participation in Citis Biopharma VIRTUAL Co-Panel Day (GlobeNewswire) -8.36%
Apr-07-22 10:46AM	Oppenheimer Sees Gains of Over 100% in These 3 Beaten-Down Stocks (TipRanks) +5.09%
Apr-01-22 06:50AM	Immuneering Announces Participation in Piper Sandler AI/ML Investor Conference (GlobeNewswire) +14.99%
Mar-24-22 06:55AM	Immuneering Announces Participation in the 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-10-22 08:46AM	Is a Surprise Coming for Immuneering (IMRX) This Earnings Season? (Zacks)
06:30AM	Immuneering Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates (GlobeNewswire)
Feb-24-22 06:50AM	Immuneering Announces Participation in March Investor Conferences (GlobeNewswire) +5.46%
Feb-07-22 08:30AM	Should You Buy Immuneering (IMRX) Ahead of Earnings? (Zacks)
Jan-31-22 12:24PM	What Is The Ownership Structure Like For Immuneering Corporation (NASDAQ:IMRX)? (Simply Wall St.)
Jan-24-22 06:50AM	Immuneering Announces Participation in Upcoming Investor Conferences (GlobeNewswire)
Jan-19-22 08:00AM	PepGen Appoints Laurie Keating as Chair of Board of Directors (GlobeNewswire)
Jan-18-22 06:50AM	Immuneering Strengthens Board of Directors with the Appointment of Diana F. Hausman, M.D. (GlobeNewswire)
Jan-06-22 04:10PM	Immuneering Reports Compelling Preclinical Data on IMM-1-104 in NRAS Mutant Melanoma Model And Will Host Key External Expert Investor Event (GlobeNewswire) -8.66% +9.41%
Jan-03-22 06:50AM	Immuneering Appoints Rimma Steinhertz, Ph.D., PMP as Vice President, Project and Alliance Management (GlobeNewswire) +5.07%
Dec-16-21 06:50AM	Immuneering Added to the Nasdaq Biotechnology Index (GlobeNewswire)
Nov-18-21 06:35AM	Immuneering Announces Participation in December Investor Conferences (GlobeNewswire)

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Cormorant Asset Management, LP	10% Owner	Apr 01 '24	Sale	2.90	400,000	1,160,181	2,895,273	Apr 03 05:37 PM
Schall Thomas J.	Director	Mar 22 '24	Buy	2.55	2,900	7,385	2,900	Mar 25 04:03 PM
Feinberg Peter	Director	Mar 22 '24	Buy	2.55	25,000	63,713	111,766	Mar 25 09:13 AM
Brakewood Harold Eugene	Chief Business Officer	Mar 22 '24	Buy	2.57	3,900	10,015	3,900	Mar 25 09:10 AM
Morales Mallory	Chief Accounting Officer	Mar 21 '24	Buy	2.72	1,107	3,009	7,885	Mar 25 09:04 AM
Morales Mallory	Chief Accounting Officer	Mar 22 '24	Buy	2.55	393	1,000	8,278	Mar 25 09:04 AM
Neufeld Leah R	CHIEF PEOPLE OFFICER	Mar 20 '24	Buy	2.88	3,818	10,993	10,029	Mar 21 09:11 AM
Hall Brett Matthew	CHIEF SCIENTIFIC OFFICER	Mar 20 '24	Buy	2.86	7,000	20,020	345,896	Mar 21 09:06 AM
BERMAN ANN E	Director	Mar 18 '24	Buy	2.13	57,965	123,436	67,465	Mar 19 07:10 PM
Feinberg Peter	Director	Mar 18 '24	Buy	2.38	50,000	119,058	61,766	Mar 19 07:04 PM
Feinberg Peter	Director	Mar 19 '24	Buy	2.56	25,000	64,000	86,766	Mar 19 07:04 PM
Zeskind Benjamin J.	PRESIDENT AND CEO	Mar 19 '24	Buy	2.77	20,000	55,326	2,281,852	Mar 19 06:59 PM
Cormorant Asset Management, LP	10% Owner	Mar 14 '24	Sale	3.72	509,091	1,892,603	3,695,273	Mar 18 05:59 PM
Cormorant Asset Management, LP	10% Owner	Mar 15 '24	Sale	2.14	400,000	856,400	3,295,273	Mar 18 05:59 PM

L

Loews Corp.

IMRX

Immuneering Corp

Upgrade your FINVIZ experience